Regulation of mouse intestinal L cell progenitors proliferation by the glucagon family of peptides

Endocrinology

Volumn 153, Issue 7, 2012, Pages 3076-3088

  Grigoryan, Marine ^a   Kedees, Mamdouh H ^a   Charron, Maureen J ^b   Guz, Yelena ^a   Teitelman, Gladys ^a  

^a STATE UNIVERSITY OF NEW YORK   (United States)

^b ALBERT EINSTEIN COLLEGE OF MEDICINE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

CASPASE 3; EXENDIN 9 39; GLUCAGON LIKE PEPTIDE 1; GLUCAGON LIKE PEPTIDE 2; GLUCAGON RECEPTOR; HORMONE RECEPTOR BLOCKING AGENT; MESSENGER RNA; TRANSCRIPTION FACTOR; UNCLASSIFIED DRUG;

ANIMAL CELL; ANIMAL TISSUE; APOPTOSIS; ARTICLE; CELL COUNT; CELL HYPERPLASIA; CELL MATURATION; CELL PROLIFERATION; CONTROLLED STUDY; GENE DELETION; GOBLET CELL; INTESTINE CELL; INTESTINE EPITHELIUM CELL; INTESTINE L CELL; INTRACELLULAR SIGNALING; MALE; MOUSE; NONHUMAN; PARACRINE SIGNALING; PRIORITY JOURNAL; PROTEIN EXPRESSION; SMALL INTESTINE; STEM CELL;

ANIMALS; APOPTOSIS; CELL CYCLE; CELL PROLIFERATION; CROSSES, GENETIC; ENTEROENDOCRINE CELLS; GENE EXPRESSION REGULATION; GLUCAGON; GOBLET CELLS; INTESTINES; MALE; MICE; MICE, KNOCKOUT; MICE, TRANSGENIC; NEURONS; PEPTIDES; RNA, MESSENGER;

EID: 84862746869     PISSN: 00137227     EISSN: 19457170     Source Type: Journal    
DOI: 10.1210/en.2012-1120     Document Type: Article

References (74)

1. Booth C, Potten CS 2000 Gut instincts: thoughts on intestinal epithelial stem cells. J Clin Invest 105:1493-1499 (Pubitemid 30390294)
2. Cheng H, Leblond CP 1974 Origin, differentiation and renewal of the four main epithelial cell types in the mouse small intestine. III. Entero-endocrine cells. Am J Anat 141:503-519
3. Haegebarth A, Clevers H 2009 Wnt signaling, lgr5, and stem cells in the intestine and skin. Am J Pathol 174:715-721
4. Sato T, Vries RG, Snippert HJ, van de Wetering M, Barker N, Stange DE, van Es JH, Abo A, Kujala P, Peters PJ, Clevers H 2009. Single Lgr5 stem cells build crypt-villus structures in vitro without a mesenchymal niche. Nature 459:262-265
5. Cheng H, Leblond CP 1974 Origin, differentiation and renewal of the four main epithelial cell types in the mouse small intestine. V. Unitarian theory of the origin of the four epithelial cell types. Am J Anat 141:537-561
6. Schonhoff SE, Giel-Moloney M, Leiter AB 2004 Development and differentiation of gut endocrine cells. Endocrinology 145:2639-2644 (Pubitemid 38686209)
7. Kieffer TJ, Habener JF 1999 The glucagon-like peptides. Endocrine Reviews 20:876-913 (Pubitemid 30647076)
8. Drucker DJ 2006 The biology of incretin hormones. Cell Metab 3:153-165
9. Holst JJ 1997 Enteroglucagon. Annu Rev Physiol 59:257-271 (Pubitemid 27142442)
10. Furuta M, Yano H, Zhou A, Rouillé Y, Holst JJ, Carroll R, Ravazzola M, Orci L, Furuta H, Steiner DF 1997 Defective prohormone processing and altered pancreatic islet morphology in mice lacking active SPC2. Proc Natl Acad Sci USA 94:6646-6651 (Pubitemid 27281918)
11. Crosnier C, Stamataki D, Lewis J 2006 Organizing cell renewal in the intestine: stem cells, signals and combinatorial control. Nat Rev Genet 7:349-359
12. Drucker DJ 2005 Biologic actions and therapeutic potential of the proglucagon-derived peptides. Nat Clin Pract Endocrinol Metab 1:22-31
13. Göke R, Fehmann HC, Linn T, Schmidt H, Krause M, Eng J, Göke B 1993 Exendin-4 is a high potency agonist and truncated exendin-(9-39)-amide an antagonist at the glucagon-like peptide 1-(7-36)-amide receptor of insulin-secreting β-cells. J Biol Chem 268:19650-19655 (Pubitemid 23270754)
14. Drucker DJ 2002 Gut adaptation and the glucagon-like peptides. Gut 50:428-435 (Pubitemid 34161064)
15. Thorens B 1992 Expression cloning of the pancreatic β cell receptor for the gluco-incretin hormone glucagon-like peptide 1. Proc Natl Acad Sci USA 89:8641-8645
16. Gelling RW, Du XQ, Dichmann DS, Romer J, Huang H, Cui L, Obici S, Tang B, Holst JJ, Fledelius C, Johansen PB, Rossetti L, Jelicks LA, Serup P, Nishimura E, Charron MJ 2003 Lower blood glucose, hyperglucagonemia, and pancreatic α-cell hyperplasia in glucagon receptor knockout mice. Proc Natl Acad Sci USA 100: 1438-1443 (Pubitemid 36184020)
17. Ali S, Lamont BJ, Charron MJ, Drucker DJ 2011 Dual elimination of the glucagon and GLP-1 receptors in mice reveals plasticity in the incretin axis. J Clin Invest 121:1917-1929
18. Vuguin PM, Kedees MH, Cui L, Guz Y, Gelling RW, Nejathaim M, Charron MJ, Teitelman G 2006 Ablation of the glucagon receptor gene increases fetal lethality and produces alterations in islet development and maturation. Endocrinology 147:3995-4006 (Pubitemid 44268351)
19. Tornehave D, Kristensen P, Rømer J, Knudsen LB, Heller RS 2008 Expression of the GLP-1 receptor in mouse, rat, and human pancreas. J Histochem Cytochem 56:841-851
20. Heller RS, Kieffer TJ, Habener JF 1997 Insulinotropic glucagon-like peptide I receptor expression in glucagon-producing α-cells of the rat endocrine pancreas. Diabetes 46:785-791 (Pubitemid 27188255)
21. Escobar M, Nicolas P, Sangar F, Laurent-Chabalier S, Clair P, Joubert D, Jay P, Legraverend C 2011 Intestinal epithelial stem cells do not protect their genome by asymmetric chromosome segregation. Nat Commun 2:258
22. Weiser MM, Ryzowicz S, Soroka CJ, Albini B 1987 In vitro translation of rat intestinal RNA prepared from isolated villus and crypt cells and from the epithelium-denuded intestine. Synthesis of intestinal basement membrane. Trans Assoc Am Physicians 100:316-328
23. Hadjiyanni I, Baggio LL, Poussier P, Drucker DJ 2008 Exendin-4 modulates diabetes onset in nonobese diabetic mice. Endocrinology 149:1338-1349 (Pubitemid 351397945)
24. Mu J, Woods J, Zhou YP, Roy RS, Li Z, Zycband E, Feng Y, Zhu L, Li C, Howard AD, Moller DE, Thornberry NA, Zhang BB 2006 Chronic inhibition of dipeptidyl peptidase-4 with a sitagliptin analog preserves pancreatic β-cell mass and function in a rodent model of type 2 diabetes. Diabetes 55:1695-1704 (Pubitemid 44324122)
25. Kim SJ, Nian C, Doudet DJ, McIntosh CH 2008 Inhibition of dipeptidyl peptidase IV with sitagliptin (MK0431) prolongs islet graft survival in streptozotocin-induced diabetic mice. Diabetes 57:1331-1339
26. Kedees MH, Grigoryan M, Guz Y, Teitelman G 2009 Differential expression of glucagon and glucagon-like peptide 1 receptors in mouse pancreatic α and β cells in two models of α cell hyperplasia. Mol Cell Endocrinol 311:69-76
27. Rothman KJ 1990 Statistics in nonrandomized studies. Epidemiology 1:417-418
28. Mortensen K, Christensen LL, Holst JJ, Orskov C 2003 GLP-1 and GIP are colocalized in a subset of endocrine cells in the small intestine. Regul Pept 114:189-196 (Pubitemid 36773884)
29. Theodorakis MJ, Carlson O, Michopoulos S, Doyle ME, Juhaszova M, Petraki K, Egan JM 2006 Human duodenal enteroendocrine cells: source of both incretin peptides, GLP-1 and GIP. Am J Physiol Endocrinol Metab 290:E550-E559 (Pubitemid 43671703)
30. Ahlgren U, Jonsson J, Edlund H 1996 Arrested development of the pancreas in IPF1/Pdx-1 deficient mice reveals that the pancreatic mesenchyme develops independently of the pancreatic epithelium. Development 122:1409-1416
31. Offield MF, Jetton TL, Labosky PA, Ray M, Stein RW, Magnuson MA, Hogan BL, Wright CV 1996 PDX-1 is required for pancreatic outgrowth and differentiation of the rostral duodenum. Development 122:983-995 (Pubitemid 26096002)
32. Fujita Y, Chui JW, King DS, Zhang T, Seufert J, Pownall S, Cheung AT, Kieffer TJ 2008 Pax6 and Pdx1 are required for production of glucose-dependent insulinotropic polypeptide in proglucagon-expressing L cells. Am J Physiol Endocrinol Metab 295:E648-E657
33. Jepeal LI, Fujitani Y, Boylan MO, Wilson CN, Wright CV, Wolfe MM 2005 Cell-specific expression of glucose-dependent-insulinotropic polypeptide is regulated by the transcription factor PDX-1. Endocrinology 146:383-391 (Pubitemid 40051762)
34. Drucker DJ, Erlich P, Asa SL, Brubaker PL 1996 Induction of intestinal epithelial proliferation by glucagon-like peptide 2. Proc Natl Acad Sci USA 93:7911-7916 (Pubitemid 26277138)
35. Deacon CF, Knudsen LB, Madsen K, Wiberg FC, Jacobsen O, Holst JJ 1998 Dipeptidyl peptidase IV resistant analogues of glucagon-like peptide-1 which have extended metabolic stability and improved biological activity. Diabetologia 41:271-278 (Pubitemid 28254820)
36. Drucker DJ 2003 Glucagon-like peptides: regulators of cell proliferation, differentiation, and apoptosis. Mol Endocrinol 17:161-171 (Pubitemid 36183142)
37. Rowland KJ, Brubaker PL 2008 Life in the crypt: a role for glucagonlike peptide-2? Mol Cell Endocrinol 288:63-70
38. Aiken KD, Roth KA 1992 Temporal differentiation and migration of substance P, serotonin, and secretin immunoreactive enteroendocrine cells in the mouse proximal small intestine. Dev Dyn 194: 303-310 (Pubitemid 23015685)
39. Barker N, van de Wetering M, Clevers H 2008 The intestinal stem cell. Genes Dev 22:1856-1864 (Pubitemid 352008634)
40. van der Flier LG, Clevers H 2009 Stem cells, self-renewal, and differentiation in the intestinal epithelium. Annu Rev Physiol 71:241-260
41. Drucker DJ 2007 The role of gut hormones in glucose homeostasis. J Clin Invest 117:24-32 (Pubitemid 46048446)
42. -/- mice by lowering cAMP in pancreatic β-cells and inhibiting insulin secretion. J Biol Chem 283:25786-25793
43. De León DD, Deng S, Madani R, Ahima RS, Drucker DJ, Stoffers DA 2003 Role of endogenous glucagon-like peptide-1 in islet regeneration after partial pancreatectomy. Diabetes 52:365-371 (Pubitemid 36173191)
44. Baggio L, Kieffer TJ, Drucker DJ 2000 Glucagon-like peptide-1, but not glucose-dependent insulinotropic peptide, regulates fasting glycemia and nonenteral glucose clearance in mice. Endocrinology 141: 3703-3709
45. Jenny M, Uhl C, Roche C, Duluc I, Guillermin V, Guillemot F, Jensen J, Kedinger M, Gradwohl G 2002 Neurogenin3 is differentially required for endocrine cell fate specification in the intestinal and gastric epithelium. EMBO J 21:6338-6347 (Pubitemid 35448412)
46. Lee CS, Perreault N, Brestelli JE, Kaestner KH 2002 Neurogenin 3 is essential for the proper specification of gastric enteroendocrine cells and the maintenance of gastric epithelial cell identity. Genes Dev 16:1488-1497 (Pubitemid 34686330)
47. Naya FJ, Huang HP, Qiu Y, Mutoh H, DeMayo FJ, Leiter AB, Tsai MJ 1997 Diabetes, defective pancreatic morphogenesis, and abnormal enteroendocrine differentiation in β2/neuroD-deficient mice. Genes Dev 11:2323-2334 (Pubitemid 27408530)
48. Trinh DK, Zhang K, Hossain M, Brubaker PL, Drucker DJ 2003 Pax-6 activates endogenous proglucagon gene expression in the rodent gastrointestinal epithelium. Diabetes 52:425-433 (Pubitemid 36173199)
49. Desai S, Loomis Z, Pugh-Bernard A, Schrunk J, Doyle MJ, Minic A, McCoy E, Sussel L 2008 Nkx2.2 regulates cell fate choice in the enteroendocrine cell lineages of the intestine. Dev Biol 313:58-66 (Pubitemid 350298302)
50. Ye DZ, Kaestner KH 2009 Foxa1 and Foxa2 control the differentiation of goblet and enteroendocrine L- and D-cells in mice. Gastroenterology 137:2052-2062
51. Chen C, Fang R, Davis C, Maravelias C, Sibley E 2009 Pdx1 inactivation restricted to the intestinal epithelium in mice alters duodenal gene expression in enterocytes and enteroendocrine cells. Am J Physiol Gastrointest Liver Physiol 297:G1126-G1137
52. Sloop KW, Cao JX, Siesky AM, Zhang HY, Bodenmiller DM, Cox AL, Jacobs SJ, Moyers JS, Owens RA, Showalter AD, Brenner MB, Raap A, Gromada J, Berridge BR, Monteith DK, Porksen N, McKay RA, Monia BP, Bhanot S, Watts LM, Michael MD 2004 Hepatic and glucagon-like peptide-1-mediated reversal of diabetes by glucagon receptor antisense oligonucleotide inhibitors. J Clin Invest 113:1571-1581 (Pubitemid 39071680)
53. Lee CS, Kaestner KH 2004 Clinical endocrinology and metabolism. Development of gut endocrine cells. Best Pract Res Clin Endocrinol Metab 18:453-462
54. Schirra J, Sturm K, Leicht P, Arnold R, Göke B, Katschinski M 1998 Exendin(9-39)amide is an antagonist of glucagon-like peptide-1(7-36)amide in humans. J Clin Invest 101:1421-1430 (Pubitemid 28166840)
55. Kolligs F, Fehmann HC, Göke R, Göke B 1995 Reduction of the incretin effect in rats by the glucagon-like peptide 1 receptor antagonist exendin (9-39) amide. Diabetes 44:16-19
56. Lovshin J, Estall J, Yusta B, Brown TJ, Drucker DJ 2001 Glucagon-like peptide (GLP)-2 action in the murine central nervous system is enhanced by elimination of GLP-1 receptor signaling. J Biol Chem 276:21489-21499
57. Gremlich S, Porret A, Hani EH, Cherif D, Vionnet N, Froguel P, Thorens B 1995 Cloning, functional expression, and chromosomal localization of the human pancreatic islet glucose-dependent insulinotropic polypeptide receptor. Diabetes 44:1202-1208
58. Wheeler MB, Gelling RW, McIntosh CH, Georgiou J, Brown JC, Pederson RA 1995 Functional expression of the rat pancreatic islet glucose-dependent insulinotropic polypeptide receptor: ligand binding and intracellular signaling properties. Endocrinology 136: 4629-4639
59. Tang-Christensen M, Larsen PJ, Thulesen J, Rømer J, Vrang N 2000 The proglucagon-derived peptide, glucagon-like peptide-2, is a neurotransmitter involved in the regulation of food intake. Nat Med 6:802-807 (Pubitemid 30469430)
60. Edwards CM, Todd JF, Mahmoudi M, Wang Z, Wang RM, Ghatei MA, Bloom SR 1999 Glucagon-like peptide 1 has a physiological role in the control of postprandial glucose in humans: studies with the antagonist exendin 9-39. Diabetes 48:86-93 (Pubitemid 29019356)
61. Lim GE, Brubaker PP 2006 Glucagon-like peptide 1 secretion by the L-cell. The view from within. Diabetes 55:S70-S77 (Pubitemid 44927035)
62. Amato A, Cinci L, Rotondo A, Serio R, Faussone-Pellegrini MS, Vannucchi MG, Mulè F 2010 Peripheral motor action of glucagonlike peptide-1 through enteric neuronal receptors. Neurogastroenterol Motil 22:664-e203
63. Amato A, Rotondo A, Cinci L, Baldassano S, Vannucchi MG, MulèF 2010 Role of cholinergic neurons in the motor effects of glucagonlike peptide-2 in mouse colon. Am J Physiol Gastrointest Liver Physiol 299:G1038-G1044
64. Körner M, Stöckli M, Waser B, Reubi JC 2007 GLP-1 receptor expression in human tumors and human normal tissues: potential for in vivo targeting. J Nucl Med 48:736-743 (Pubitemid 47604973)
65. Lundgren O, Jodal M, Jansson M, Ryberg AT, Svensson L 2011 Intestinal epithelial stem/progenitor cells are controlled by mucosal afferent nerves. PLoS One 6:e16295
66. Bjerknes M, Cheng H 2005 Gastrointestinal stem cells. II. Intestinal stem cells. Am J Physiol Gastrointest Liver Physiol 289:G381-G387 (Pubitemid 41216374)
67. Totafurno J, Bjerknes M, Cheng H 1987 The crypt cycle. Crypt and villus production in the adult intestinal epithelium. Biophys J 52: 279-294
68. Dubé PE, Rowland KJ, Brubaker PL 2008 Glucagon-like peptide-2 activates β-catenin signaling in the mouse intestinal crypt: role of insulin-like growth factor-I. Endocrinology 149:291-301
69. Daoudi M, Hennuyer N, Borland MG, Touche V, Duhem C, Gross B, Caiazzo R, Kerr-Conte J, Pattou F, Peters JM, Staels B, Lestavel S 2011 PPARβ/δ activation induces enteroendocrine L cell GLP-1 production. Gastroenterology 140:1564-1574
70. Bosse T, Piaseckyj CM, Burghard E, Fialkovich JJ, Rajagopal S, Pu WT, Krasinski SD 2006 Gata4 is essential for the maintenance of jejunal-ileal identities in the adult mouse small intestine. Mol Cell Biol 26:9060-9070 (Pubitemid 44851961)
71. Stoffers DA, Kieffer TJ, Hussain MA, Drucker DJ, Bonner-Weir S, Habener JF, Egan JM 2000 Insulinotropic glucagon-like peptide 1 agonists stimulate expression of homeodomain protein IDX-1 and increase islet size in mouse pancreas. Diabetes 49:741-748 (Pubitemid 30339989)
72. Näslund E, Backman L, Holst JJ, Theodorsson E, Hellström PM 1998 Importance of small bowel peptides for the improved glucose metabolism 20 years after jejunoileal bypass for obesity. Obes Surg 8:253-260 (Pubitemid 28334120)
73. Laferrère B 2009 Effect of gastric bypass surgery on the incretins. Diabetes Metab 35:513-517
74. Speck M, Cho YM, Asadi A, Rubino F, Kieffer TJ 2011 Duodenal-jejunal bypass protects GK rats from β-cell loss and aggravation of hyperglycemia and increases enteroendocrine cells coexpressing GIP and GLP-1. American journal of physiology. Endocrinology and metabolism 300:E923-932